Skip to main content
Figure 1 | BMC Clinical Pharmacology

Figure 1

From: Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study

Figure 1

Changes in lipid profile with simvastatin and fenofibrate therapy. All lipid parameters including apoB improve significantly with both simvastatin and fenofibrate treatment. However, the reduction in total cholesterol, LDL-C and apoB (as indicated by the uppermost bar) were significantly higher with simvastatin than fenofibrate. * p < 0.05 vs baseline; † p < 0.05 vs other drug.

Back to article page

BMC Clinical Pharmacology

ISSN: 1472-6904